Showing results (201-210 of 212) with videos related to
Sort By:
Pageof 22
American Heart Journal|September 26, 2006
The impact of emergency department structure and care processes in delivering care for non-ST-segment elevation acute coronary syndromesRajendra H Mehta, L Kristin Newby, Yogin Patel, et al.European Heart Journal|April 3, 2009
Prior polyvascular disease: risk factor for adverse ischaemic outcomes in acute coronary syndromesDeepak L Bhatt, Eric D Peterson, Robert A Harrington, et al.The New England Journal of Medicine|June 23, 2015
Idarucizumab for Dabigatran ReversalCharles V Pollack, Paul A Reilly, John Eikelboom, et al.European Heart Journal. Acute Cardiovascular Care|October 21, 2020
Outcomes in non-ST-segment elevation myocardial infarction patients according to heart failure at admission: Insights from a large trial with systematic early invasive strategyBatric Popovic, Emmanuel Sorbets, Jeremie Abtan, et al.Annals of Emergency Medicine|June 27, 2002
A study of the workforce in emergency medicine: 1999John C Moorhead, Michael E Gallery, Colleen Hirshkorn, et al.NEJM Evidence|February 6, 2024
Bentracimab for Ticagrelor Reversal in Patients Undergoing Urgent SurgeryDeepak L Bhatt, Charles V Pollack, C David Mazer, et al.The New England Journal of Medicine|November 17, 2009
Platelet inhibition with cangrelor in patients undergoing PCIRobert A Harrington, Gregg W Stone, Steven McNulty, et al.The New England Journal of Medicine|July 12, 2017
Idarucizumab for Dabigatran Reversal - Full Cohort AnalysisCharles V Pollack, Paul A Reilly, Joanne van Ryn, et al.The New England Journal of Medicine|November 17, 2009
Intravenous platelet blockade with cangrelor during PCIDeepak L Bhatt, A Michael Lincoff, C Michael Gibson, et al.Circulation. Cardiovascular Quality and Outcomes|March 1, 2012
Regional patterns of use of a medical management strategy for patients with non-ST-segment elevation acute coronary syndromes: insights from the EARLY ACS TrialMatthew T Roe, Jennifer A White, Padma Kaul, et al.Pageof 22